-
HC Wainwright Reaffirms "Buy" Rating for Karyopharm Therapeutics (NASDAQ:KPTI)
来源: Buzz FX / 21 2月 2025 08:38:13 America/New_York
HC Wainwright Reaffirms "Buy" Rating for Karyopharm Therapeutics (NASDAQ:KPTI) Written by MarketBeat February 21, 2025 Share Link copied to clipboard. Karyopharm Therapeutics ( NASDAQ:KPTI - Get Free Report ) 's stock had its "buy" rating r
Read more...